Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2014
12/02/2014US8901154 High concentration topical insecticides containing pyrethroids
12/02/2014US8901131 Gatifloxacin-containing ophthalmic gel and preparation method thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901128 Pharmaceutical compositions of ranolazine
12/02/2014US8901113 Methods and compositions for deterring abuse
12/02/2014US8901100 Tumor-specific delivery of therapeutic agents via liposomase
12/02/2014US8901090 Method of treating otitis externa using macrocyclic lactone compound
12/02/2014US8901071 Compounds and their use
12/02/2014US8900865 Blood brain barrier device
12/02/2014US8900806 Antibody preparations
12/02/2014US8900643 Method of treatment using a therapeutic agent for intranasal administration
12/02/2014US8900642 Calcium carbonate granulation
12/02/2014US8900640 Expandable, porous apatite/collagen composite, and its production method
12/02/2014US8900638 Solid preparation comprising alogliptin and metformin hydrochloride
12/02/2014US8900637 Stable taste masked formulations of cephalosporins
12/02/2014US8900636 Controlled release compositions
12/02/2014US8900635 Nanoparticle isoflavone compositions and methods of making and using the same
12/02/2014US8900634 Diethylstilbestrol dosage form and methods of treatment using thereof
12/02/2014US8900633 Method for producing a product having a polymer matrix, implants made thereof and use thereof
12/02/2014US8900632 Rapidly disintegrating coated tablets
12/02/2014US8900631 Dosage form to increase prasterone bioavailability
12/02/2014US8900630 Microcapsules having multiple shells and method for the preparation thereof
12/02/2014US8900629 Rapidly dissolving pharmaceutical compositions comprising pullulan
12/02/2014US8900628 Hard capsule and method for producing same
12/02/2014US8900627 Compositions for the in vivo delivery of RNAi agents
12/02/2014US8900626 Transdermal drug delivery system and method of using the same
12/02/2014US8900625 Antimicrobial compounds and methods of use
12/02/2014US8900624 Antimicrobial silver compositions
12/02/2014US8900623 Sticky soft gel for treating poultry
12/02/2014US8900622 Hypotensive lipid-containing biodegradable intraocular implants and related methods
12/02/2014US8900621 Polyamine derivatives
12/02/2014US8900616 System and method for satellite drug delivery
12/02/2014US8900615 Drug delivery system
12/02/2014US8900614 Intra-oral device for treating obesity
12/02/2014US8900606 Methods of applying coating materials for solid medicines
12/02/2014US8900605 Solid ivabradine-containing composition
12/02/2014US8900604 Fatty acid conjugates of quetiapine, process for making and using the same
12/02/2014US8900602 Disintegrating particle composition and orally rapidly disintegrating tablet
12/02/2014US8900601 Permeable mixtures, methods and compositions for the skin
12/02/2014US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof
12/02/2014US8900583 Methods for treatment of brain injury utilizing biologics
12/02/2014US8900575 Compositions and methods for oxalate reduction
12/02/2014US8900562 Semi-fluorinated block copolymers for delivery of therapeutic agents
12/02/2014US8900557 Dental cleaning composition
12/02/2014US8900555 Insulin derivative formulations for pulmonary delivery
12/02/2014US8900554 Foamable composition and uses thereof
12/02/2014US8900553 Oil and liquid silicone foamable carriers and formulations
12/02/2014US8900550 Catalytic radiofluorination
12/02/2014US8900218 Infusion of drugs
12/02/2014US8900194 Microneedle devices and microneedle delivery apparatus
12/02/2014US8900180 Coatable compositions, coatings derived therefrom and microarrays having such coatings
12/02/2014US8899239 Electronic cigarette
11/2014
11/27/2014US20140350493 Dermal delivery device with in situ seal
11/27/2014US20140350465 Devices and Methods for Delivering Therapeutic Substances for the Treatment of Sinusitis and Other Disorders
11/27/2014US20140350457 Method of coating microneedle devices
11/27/2014US20140350323 Particulate System For Use in Diminishing Cell Growth/Inducing Cell Killing
11/27/2014US20140350118 Topical compositions and methods for making and using same
11/27/2014US20140350114 Compositions comprising cyclohexylamines and aminoadamantanes
11/27/2014US20140350104 Methods and compositions for reducing body fat and adipocytes
11/27/2014US20140350101 Gel compositions
11/27/2014US20140350066 Compositions and their uses for gene therapy of bone conditions
11/27/2014US20140350063 Biotherapeutics for the treatment of infectious diseases
11/27/2014US20140350054 Small-volume oral transmucosal dosage forms
11/27/2014US20140350028 Pulmonary delivery of a fluoroquinolone
11/27/2014US20140350027 Pharmaceutical Compositions Comprising Imatinib and a Release Retardant
11/27/2014US20140349983 Method for treating ulcerative colitis
11/27/2014US20140349982 Methods of treating ulcerative colitis
11/27/2014US20140349979 Stabilized modified release vitamin d formulation and method of administering same
11/27/2014US20140349978 Salicylic Acid Gel
11/27/2014US20140349940 Prevention and reduction of blood loss
11/27/2014US20140349936 Compositions and methods for treating precocious puberty
11/27/2014US20140348962 Method for Providing an Ingestible Nutritional Supplement to a Woman
11/27/2014US20140348956 Scleral lens solution
11/27/2014US20140348954 Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
11/27/2014US20140348938 Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
11/27/2014US20140348936 Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermoplastic polyurethanes
11/27/2014US20140348934 Rotary die system
11/27/2014US20140348931 Sustained-release topiramate formulations
11/27/2014US20140348926 Formulation and method for increasing oral bioavailability of drugs
11/27/2014US20140348922 Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-l-ascorbic acid
11/27/2014US20140348918 Delayed-release glucocorticoid treatment of asthma
11/27/2014US20140348917 Immediate release formulations and dosage forms of gamma-hydroxybutyrate
11/27/2014US20140348916 Treatment of Pain with Oral Dosage Forms Comprising Zoledronic Acid and An Enhancer
11/27/2014US20140348915 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
11/27/2014US20140348914 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
11/27/2014US20140348913 Bitter crude drug-comprising granular product
11/27/2014US20140348912 Capsule for encapsulating a tablet
11/27/2014US20140348911 Spray formulation of mesenchymal stem cells for the treatment of chronic wounds
11/27/2014US20140348910 Topical Formulations Including Lipid Microcapsule Delivery Vehicles and Their Uses
11/27/2014US20140348909 Pharmaceutical compositions of lurasidone
11/27/2014US20140348905 Gel compositions
11/27/2014US20140348900 Methods and devices for preparation of lipid nanoparticles
11/27/2014US20140348899 Method and composition for treating cystitis
11/27/2014US20140348898 Local administration of gallium compositions to treat pain
11/27/2014US20140348895 Para-xylene films and therapeutic uses thereof
11/27/2014US20140348879 Enteric soft capsules
11/27/2014US20140348852 Method for making precipitated particles
11/27/2014US20140348815 Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
11/27/2014US20140348811 Compositions comprising sugar-cysteine products
11/27/2014US20140348795 Nutritional beverage powder and method of making same
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 2991